Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation

British Journal of Ophthalmology

Volumn 89, Issue 9, 2005, Pages 1109-1111

  Hogan, A ^a   Behan, U ^a   Kilmartin, Dara J ^a  

^a ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TRIAMCINOLONE;

ADULT; CHOROIDITIS; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

ADULT; ANTI-INFECTIVE AGENTS; CHOROIDAL NEOVASCULARIZATION; COMBINED MODALITY THERAPY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME; TRIAMCINOLONE; VISUAL ACUITY;

EID: 24044522251     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.063024     Document Type: Review

References (20)

1. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol 1987;105:1499-507.
2. Watske RC, Packer AJ, Folk JC, et al. Punctate inner choroidopathy. Am J Ophthalmol 1984;98:572-84.
3. Rogers AH, Duker JS, Nichols N, et al. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003;110:1315-20.
4. Wachtlin J, Heimann H, Behme T, et al. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularization secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol 2003;241:899-906.
5. Rosenfeld PJ, Saperstein DA, Bressler NM, et al. Verteporfin in Ocular Histoplasmosis Study Group. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label-2-year study, Ophthalmology 2004;111:1725-33.
6. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP Report 1. Arch Ophthalmol 1999;117:1329-45.
7. Flaxel G, Owens SL, Mulholland B, et al. The use of corticosteroids for choroidal neovascularization in young patients. Eye 1998;12:266-72.
8. Martidis A, Miller DG, Ciulla TG, et al. Corticosteroids as an antiangiogenic agent for Histoplasmosis-related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther 1999;15:425-8.
9. Olsen TW, Capone A Jr, Sternberg P Jr, et al. ubfoveal choroidal neovascularization in punctuate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 1996;103:2061-9.
10. Spaide RF, Freund KB, Slakter J, et al. Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 2002;22:545-9.
11. Dees C, Arnold JJ, Forrester JV, et al. Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. Arch Ophthalmol 1998;116:1456-61.
12. Kilmartin DJ, Forrester JV, Dick AD. Rescue therapy with mycophenolate mofetil in refractory uveitis. Lancet 1998;352:25-6.
13. Kilmartin DJ, Forrester JV, Dick AD. Tacrolimus (FK506) in failed cyclosporine A therapy in endogenous posterior uveitis. Ocul Immunol Inflamm 1998;6:101-9.
14. Groosniklaus HE, Green WR. Histopatholgic and ultrastructural findings of surgically excised choroidal neovascularization. Arch Ophthalmol 1998;116:745-9.
15. Kwak N, Okamoto N, Wood JM, et al. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 2000;41:3158-64.
16. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1999;40:1891-1898.
17. Hunt DW, Jiang H, Granville DJ, et al. Consequences of photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology 1999;41:31-44.
18. Simkin GO, Tao JS, Levy LG, et al. IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy. J Immunol 2000;164:2457-62.
19. Rechtman E, Allen VD, Danis RP, et al. Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol 2003;136(4):739-41.
20. Rechtman E, Danis RP, Pratt LM, et al. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age related macular degeneration. Br J Ophthalmol 2004;88:344-7.